ASQ Certified Pharmaceutical GMP Professional Examination Practice Test
Pharmaceutical GMP work depends on controlled manufacturing records, reliable testing, qualified equipment, and decisions that protect product quality. CPGP practice topics include handling documentation omissions, investigating audit findings, assessing incoming components, and controlling changes to suppliers or processes. These subjects connect production-floor practices with the quality systems used to maintain product identity, strength, quality, and purity.
Exam overview
About the ASQ Certified Pharmaceutical GMP Professional Examination Exam
The question bank samples decisions that require traceable evidence and appropriate quality oversight. Scenarios address correcting a missing batch-record entry without obscuring the original record, assessing the scope of an audit observation, and determining whether a component discrepancy requires investigation before use. Other items cover contract-laboratory agreements, reference and retention samples, returned-product disposition, independent batch release decisions, supplier changes, equipment qualification, and process-validation protocols. Use these situations to practice distinguishing immediate containment from investigation and final disposition, identifying records that support a decision, and recognizing when quality-unit involvement is needed. The questions also connect lifecycle controls—such as qualification and validation—to evidence that manufacturing methods and equipment perform as intended.
Sample Practice Questions
Review a selection from this exam's published US Practice Tests practice bank.
A batch record contains a missing operator entry for a completed manufacturing step. What is the appropriate way to address the omission?
Show answer
Correct answer: AGMP records should remain attributable, legible, contemporaneous, original, and accurate. A correction should follow controlled procedures, preserve the original entry or omission context, and include an appropriate explanation rather than conceal or fabricate information.
During an internal GMP audit, an auditor identifies a potential issue but cannot yet determine its scope. What is the best next step?
Show answer
Correct answer: AAudit conclusions should be supported by objective evidence. When scope is uncertain, gathering and documenting relevant information supports a fair assessment and appropriate follow-up without prejudging the outcome.
A batch is made using a packaging component that has a different appearance from the approved description, although its identifying information appears correct. What should the site do before using it?
Show answer
Correct answer: BA component with an unexpected appearance should not be accepted for use based on informal recognition or an undocumented assurance. It should be held while its identity, status, and conformity with approved requirements are assessed through the quality system.
A manufacturer is preparing a written agreement with a contract laboratory that performs GMP testing. Which provision is especially important?
Show answer
Correct answer: AA clear quality or technical agreement defines the parties’ responsibilities and communication pathways for GMP activities. This supports consistent testing, appropriate record access, and timely handling of issues.
A manufacturer is creating a program for managing reference and retention samples. Which practice best supports their intended use?
Show answer
Correct answer: ASamples must remain identifiable and appropriately stored so they can support specified testing, investigation, or reference purposes. Records should make their location and status traceable.
A firm receives a returned medicinal product from a distributor. What is the appropriate disposition approach?
Show answer
Correct answer: BReturned products require controlled assessment. Relevant factors include the product's identity and condition, chain of custody, storage and transport conditions, and applicable procedures and regulations; the product should not be returned to saleable stock by assumption.
A manufacturer is assigning responsibilities for independent quality oversight of batch disposition. Which arrangement best supports impartial decisions?
Show answer
Correct answer: BIndependent quality oversight supports objective review of batch records and relevant quality information before disposition. The responsible quality function needs appropriate authority and qualified personnel.
How to use this practice test
The free US Practice Tests practice bank contains 50 published questions; each session presents up to 20 selected at random. Answer questions as if documenting a real GMP decision, then use the displayed results to identify topics to revisit, such as record corrections, supplier changes, qualification, or validation.
Preparation tips
- For batch-record scenarios, identify how to correct an omission with a dated, attributable entry that preserves the original record and explains the correction where appropriate.
- For audit and discrepancy questions, separate immediate containment from determining scope, documenting evidence, and deciding on corrective action or disposition.
- Compare supplier, component, and contract-laboratory changes by asking what must be assessed, documented, and approved before affected materials or results are relied upon.
- Review how equipment qualification and process validation use predefined protocols, acceptance criteria, and documented results to support routine GMP use.
- For sample and returned-product scenarios, connect the proposed handling decision to sample identity, storage conditions, traceability, and documented quality disposition.